Table of Content

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in gene therapy dealmaking
2.1. Introduction
2.2. Gene therapy deals over the years
2.3. Most active gene therapy dealmakers
2.4. Gene therapy deals by deal type
2.5. Gene therapy deals by therapy area
2.6. Gene therapy deals by industry sector
2.7. Deal terms for gene therapy deals
2.7.1 Gene therapy deals headline values
2.7.2 Gene therapy deal upfront payments
2.7.3 Gene therapy deal milestone payments
2.7.4 Gene therapy royalty rates

Chapter 3 – Leading gene therapy deals
3.1. Introduction
3.2. Top gene therapy deals by value

Chapter 4 – Most active gene therapy dealmakers
4.1. Introduction
4.2. Most active gene therapy dealmakers
4.3. Most active gene therapy deals company profiles

Chapter 5 – Gene therapy contracts dealmaking directory
5.1. Introduction
5.2. Gene therapy contracts dealmaking directory

Chapter 6 – Gene therapy dealmaking by technology type

Deal directory

Deal directory – Gene therapy deals by company A-Z
Deal directory – Gene therapy deals by deal type
Deal directory – Gene therapy deals by therapy area

Deal type definitions

About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from Current Partnering

?
Table of figures

Figure 1: Gene therapy deals since 2016
Figure 2: Active gene therapy dealmaking activity – 2016 - 2023
Figure 3: Gene therapy deals by deal type since 2016
Figure 4: Gene therapy deals by therapy area since 2016
Figure 5: Gene therapy deals by industry sector since 2016
Figure 6: Gene therapy deals with a headline value
Figure 7: Gene therapy deals with an upfront value
Figure 8: Gene therapy deals with a milestone value
Figure 9: Gene therapy deals with a royalty rate value
Figure 10: Top gene therapy deals by value since 2016
Figure 11: Most active gene therapy dealmakers 2016 - 2023
Figure 12: Gene therapy deals by technology type since 2016